Michaelson, M. Dror
Massachusetts General Hospital
4 papers on CoChatORCID 0000-0001-9249-6338
Most cited papers
- Verified
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Choueiri, T. K., Bauer, T. M., Papadopoulos, K. P., Plimack, E. R., Merchan, J. R., McDermott, D. F., Michaelson, M. D., Appleman, L. J., Thamake, S., Perini, R. F., et al. (2021) · Nature Medicine
Renal cell carcinoma treatmentCancer, Hypoxia, and Metabolism
Cited by 305
- Verified
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020
Motzer, R. J., Jonasch, E., Michaelson, M. D., Nandagopal, L., Gore, J. L., George, S., Alva, A., Haas, N., Harrison, M. R., Plimack, E. R., et al. (2019) · Journal of the National Comprehensive Cancer Network
Renal cell carcinoma treatmentBladder and Urothelial Cancer Treatments
Cited by 287
- Verified
Management of Complications of Prostate Cancer Treatment
Michaelson, M. D., Cotter, S. E., Gargollo, P. C., Zietman, A. L., Dahl, D. M., & Smith, M. R. (2008) · CA: A Cancer Journal for Clinicians
Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research
Cited by 196
- Verified
Contribution of Androgen Deprivation Therapy to Elevated Osteoclast Activity in Men with Metastatic Prostate Cancer
Michaelson, M. D., Marujo, R. M., & Smith, M. R. (2004) · Clinical Cancer Research
Bone health and treatmentsProstate Cancer Treatment and Research
Cited by 60
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free